A new federal funding opportunity from the National Institutes of Health (NIH) will use $8.4 million to support clinical trials on the safety and efficacy of psychedelic-assisted therapy to treat chronic pain in older adults. An NIH notice of funding opportunity posted on Wednesday says the research can include “classic” psychedelics—including psilocybin, DMT, LSD and … Continue reading Feds Announce Plan To Fund Research On Using Psychedelics To Treat Chronic Pain In Older Adults